Dr. Lal Pathlabs reports 27% fall in Q4 consolidated net profit

18 May 2022 Evaluate

Dr. Lal Pathlabs has reported results for fourth quarter and year ended March 31, 2022.

The company has reported a fall of 17.15% in its net profit at Rs 65.20 crore for the quarter under review as compared to Rs 78.70 crore for the same quarter in the previous year. However, total income of the company increased by 2.54% at Rs 427.80 crore for Q4FY22 as compared Rs 417.20 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 27.03% in its net profit at Rs 62.10 crore for the quarter under review as compared to Rs 85.10 crore for the same quarter in the previous year. However, total income of the company increased by 11.92% at Rs 497.50 crore for Q4FY22 as compared Rs 444.50 crore for the corresponding quarter previous year.

For the year ended March 31, 2022, the company has reported a rise of 22.85% in its net profit at Rs 344.10 crore as compared to Rs 280.10 crore for the previous year. Total income of the company increased by 24.90% at Rs 1925.70 crore for year under review as compared to Rs 1541.80 crore for year ended March 31, 2021.

For the year ended March 31, 2022, on the consolidated basis, the company has reported a rise of 18.16% in its net profit at Rs 350.30 crore as compared to Rs 296.50 crore for the previous year. Total income of the company increased by 31.07% at Rs 2139.90 crore for year under review as compared to Rs 1632.60 crore for year ended March 31, 2021.

Dr. Lal Pathlabs Share Price

3025.95 -28.50 (-0.93%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×